title: Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.
authors.affiliation: Faculty of Pharmacy University of Manitoba, Winnipeg, MB.
authors.forename: Victor
authors.initials: V
authors.lastname: Fang
authors.forename: Lori D
authors.initials: LD
authors.lastname: Wazny
authors.forename: Colette B
authors.initials: CB
authors.lastname: Raymond
mesh_terms: D001549:Benzamides / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000069476:Linagliptin; D000069450:Liraglutide; D008687:Metformin / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy*; D000068900:Sitagliptin Phosphate; D045162:Thiazolidinediones / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use
chemical_list: D001549:Benzamides; D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D010455:Peptides; D011687:Purines; D011719:Pyrazines; D011799:Quinazolines; D045162:Thiazolidinediones; D014230:Triazoles; D014688:Venoms; D000069476:Linagliptin; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; C030516:meglitinide; D008687:Metformin; D000077270:Exenatide; D000068900:Sitagliptin Phosphate